| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d758be13e81bff57954d36379234dd7f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0004 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12104 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-04 |
| filingDate |
2007-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c5738e3aed7e7002206cb8db8dbc45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f00e134099d3f7662df478cca95c0d3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efcfd120136d2f4ee6d89a98f64b4d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b723a5970169c25a07279fc09dc10e4 |
| publicationDate |
2013-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2056715-B1 |
| titleOfInvention |
Functional assessment and treatment catheters |
| abstract |
Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed. |
| priorityDate |
2006-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |